Similarly, the SRC-3 level is higher in DCIS lesions compared to the corresponding normal breast tissue, and an elevated SRC-3 level in DCIS lesions causes an increase in the HER2 and HER3 levels and augments their corresponding signaling activities [204]. The gene discussed is NCOA3; the disease is ductal breast carcinoma in situ.